Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab

Alexander Hurtado; Samuel T. Luebbe; Emma Kilbane; Toluwalase Awoyemi; Taylor Bronson; Jayesh Mehta; Mohamed M.H. Al-Kazaz; Adam Y. Lin

doi:10.1016/j.jaccas.2024.102763

Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab

Alexander Hurtado, Samuel T. Luebbe, Emma Kilbane, Toluwalase Awoyemi, Taylor Bronson, Jayesh Mehta, Mohamed M.H. Al-Kazaz, Adam Y. Lin^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.

Original language	English (US)
Article number	102763
Journal	JACC: Case Reports
Volume	29
Issue number	23
DOIs	https://doi.org/10.1016/j.jaccas.2024.102763
State	Published - Dec 4 2024

Keywords

cardiac tamponade
pericardial effusion
teclistamab

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jaccas.2024.102763

Cite this

@article{4f7789109786413299466ad6aaac686d,

title = "Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab",

abstract = "Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.",

keywords = "cardiac tamponade, pericardial effusion, teclistamab",

author = "Alexander Hurtado and Luebbe, {Samuel T.} and Emma Kilbane and Toluwalase Awoyemi and Taylor Bronson and Jayesh Mehta and Al-Kazaz, {Mohamed M.H.} and Lin, {Adam Y.}",

note = "Publisher Copyright: {\textcopyright} 2024 The Authors",

year = "2024",

month = dec,

day = "4",

doi = "10.1016/j.jaccas.2024.102763",

language = "English (US)",

volume = "29",

journal = "JACC: Case Reports",

issn = "2666-0849",

publisher = "Elsevier Inc.",

number = "23",

}

TY - JOUR

T1 - Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab

AU - Hurtado, Alexander

AU - Luebbe, Samuel T.

AU - Kilbane, Emma

AU - Awoyemi, Toluwalase

AU - Bronson, Taylor

AU - Mehta, Jayesh

AU - Al-Kazaz, Mohamed M.H.

AU - Lin, Adam Y.

PY - 2024/12/4

Y1 - 2024/12/4

N2 - Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.

AB - Bispecific therapy has changed the treatment paradigm for multiple myeloma. We report a patient with recurrent malignant pericardial effusions with cardiac tamponade and new atrial fibrillation during treatment, suggesting that new or worsening pericardial disease may be a potential cardiovascular adverse effect of bispecific therapy.

KW - cardiac tamponade

KW - pericardial effusion

KW - teclistamab

UR - http://www.scopus.com/inward/record.url?scp=85209680031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85209680031&partnerID=8YFLogxK

U2 - 10.1016/j.jaccas.2024.102763

DO - 10.1016/j.jaccas.2024.102763

M3 - Article

C2 - 39691339

AN - SCOPUS:85209680031

SN - 2666-0849

VL - 29

JO - JACC: Case Reports

JF - JACC: Case Reports

IS - 23

M1 - 102763

ER -

Recurrent Cardiac Tamponade from Multiple Myeloma While Receiving Teclistamab

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this